Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Wiegering, A."'
Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells
Autor:
Otto, C., Schmidt, S., Kastner, C., Denk, S., Kettler, J., Müller, N., Germer, C.T., Wolf, E., Gallant, P., Wiegering, A.
Publikováno v:
In Neoplasia November 2019 21(11):1110-1120
Autor:
Wiegering, Armin, Matthes, Niels, Mühling, Bettina, Koospal, Monika, Quenzer, Anne, Peter, Stephanie, Germer, Christoph-Thomas, Linnebacher, Michael, Otto, Christoph
Publikováno v:
In Neoplasia April 2017 19(4):301-309
Autor:
Wiegering, Armin, Korb, Doreen, Thalheimer, Andreas, Kämmerer, Ulrike, Allmanritter, Jan, Matthes, Niels, Linnebacher, Michael, Schlegel, Nicolas, Klein, Ingo, Ergün, Süleyman, Germer, Christoph-Thomas, Otto, Christoph
Publikováno v:
In Neoplasia November 2014 16(11):972-981
Autor:
Wiegering, Armin, Korb, Doreen, Thalheimer, Andreas, Kämmerer, Ulrike, Allmanritter, Jan, Matthes, Niels, Linnebacher, Michael, Schlegel, Nicolas, Klein, Ingo, Ergün, Süleyman, Germer, Christoph-Thomas, Otto, Christoph
Publikováno v:
Neoplasia. (11):972-981
Clinical prognosis of metastasized colorectal carcinoma (CRC) is still not at desired levels and novel drugs are needed. Here, we focused on the multi-tyrosine kinase inhibitor E7080 (Lenvatinib) and assessed its therapeutic efficacy against human CR